IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase
TLDR
IRAK-4 is the closest human homolog to Pelle and depends on its kinase activity to activate NF-κB, suggesting a role of IRAK- 4 as a central element in the early signal transduction of Toll/IL-1 receptors, upstream of IRAk-1.Abstract:
Toll/IL-1 receptor family members are central components of host defense mechanisms in a variety of species. One well conserved element in their signal transduction is Ser/Thr kinases, which couple early signaling events in a receptor complex at the plasma membrane to larger signalosomes in the cytosol. The fruit fly Drosophila melanogaster has one member of this family of kinases, termed Pelle. The complexity of this pathway is vastly increased in vertebrates, and several Pelle homologs have been described and termed IL-1 receptor-associated kinase (IRAK). Here we report the identification of a novel and distinct member of the IRAK family, IRAK-4. IRAK-4 is the closest human homolog to Pelle. Endogenous IRAK-4 interacts with IRAK-1 and TRAF6 in an IL-1-dependent manner, and overexpression of IRAK-4 can activate NF-κB as well as mitogen-activated protein (MAP) kinase pathways. Most strikingly, and in contrast to the other IRAKs, IRAK-4 depends on its kinase activity to activate NF-κB. In addition, IRAK-4 is able to phosphorylate IRAK-1, and overexpression of dominant-negative IRAK-4 is blocking the IL-1-induced activation and modification of IRAK-1, suggesting a role of IRAK-4 as a central element in the early signal transduction of Toll/IL-1 receptors, upstream of IRAK-1.read more
Citations
More filters
Patent
Benzothiophene derivatives as estrogen receptor inhibitors
TL;DR: A compound of formula (I), or a pharmaceutically acceptable salt thereof, compositions, combinations and medicaments containing said compounds and processes for their preparation is defined in this article, which also relates to the use of said compounds, combinations, compositions and medications, for example as inhibitors of the activity of the estrogen receptor.
Journal ArticleDOI
Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication.
Teslin S. Sandstrom,Teslin S. Sandstrom,Nischal Ranganath,Nischal Ranganath,Jonathan B. Angel,Jonathan B. Angel,Jonathan B. Angel +6 more
TL;DR: Understanding how IFN1 signalling is blocked in physiologically-relevant models of HIV-1 infection, and whether these defects can be reversed, is of great importance for the development of novel therapeutic strategies aimed at eradicating the HIV- 1 reservoir.
Journal ArticleDOI
Recent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4
TL;DR: The structural aspect of ligand recognition by IRAK4 is discussed and its therapeutic importance in the context of TLR-associated unmet medical needs is highlighted, which will be crucial for the development of new inhibitors with improved potencies.
Book ChapterDOI
Chapter Nine - Advances in the Discovery of Small-Molecule IRAK4 Inhibitors
John Hynes,Satheesh K. Nair +1 more
TL;DR: Therapeutic targeting of innate immune system pathways in chronic inflammatory diseases, such as rheumatoid arthritis and lupus, may provide additional therapies for patients afflicted with these conditions with an attractive alternative for targeting this pathway, IRAK4.
Journal ArticleDOI
Anti-inflammatory effect of berkeleyacetal C through the inhibition of interleukin-1 receptor-associated kinase-4 activity
TL;DR: It is suggested that BAC inhibits LPS- and PGN- induced NO production and iNOS expression by decreasing the level of the translocating of NF-κB in nuclear through inhibiting the kinase activity of IRAK-4 in inflammatory cells.
References
More filters
Journal ArticleDOI
Biologic basis for interleukin-1 in disease
TL;DR: This is a lengthy review, with 586 citations chosen to illustrate specific areas of interest rather than a compendium of references, which summarizes what the author considers established or controversial topics linking the biology of IL-1 to mechanisms of disease.
Journal ArticleDOI
TRAF6 is a signal transducer for interleukin-1
TL;DR: The identification of a new TRAF family member is reported, designated TRAF6, which indicates that TRAF proteins may function as signal transducers for distinct receptor families and that TRAf6 participates in IL-1 signalling.
Journal ArticleDOI
MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1.
TL;DR: The findings indicate that NIK participates in an NF-KB-inducing signalling cascade common to receptors of the TNF/NGF family and to the interleukin-1 type-I receptor.
Journal ArticleDOI
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction
Katherine A. Fitzgerald,Eva M. Palsson-McDermott,Andrew G. Bowie,Andrew G. Bowie,Caroline A. Jefferies,Ashley Mansell,Gerard Brady,Elizabeth Brint,Aisling Dunne,Pearl Gray,Mary T. Harte,Diane McMurray,Dirk E. Smith,John E. Sims,T. A. Bird,Luke A. J. O'Neill +15 more
TL;DR: A protein is described, Mal (MyD88-adapter-like), which joins MyD88 as a cytoplasmic TIR-domain-containing protein in the human genome, which is therefore an adapter in TLR-4 signal transduction.
Journal ArticleDOI
IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK
TL;DR: Overexpression of a catalytically inactive form of IKK-β blocked cytokine-induced NF-κB activation and suggested that an active IκB kinase complex may require three distinct protein kinases.